British language technology provider RWS acquires Acolad parent Acogroup at an enterprise value of £22.4 million, the company confirmed on Monday. The Maidenhead-based group closed the deal following clearance from French economic authorities and works council consultations, absorbing a European competitor that generated £182 million in revenue last year.
Key points
- RWS completed its takeover of Acogroup for a total consideration of £40.2 million, which includes £17.8 million of cash acquired on the balance sheet.
- The transaction values the French language services provider at an enterprise value of £22.4 million, equivalent to two times projected adjusted EBITDA.
- Acolad brings roughly 1,200 staff across 22 countries, high exposure to regulated European industries, and relationships with half of France’s CAC 40 companies.
- The French business will join the RWS Transform division, integrating proprietary tools such as Language Weaver Pro and Trados.
Inside the £22.4 million transaction
RWS Holdings plc completed the transaction through its subsidiary, RWS Global Holdings Limited, concluding a takeover process that was first announced in August 2026. While the enterprise value stands at £22.4 million, the total headline cash outlay amounts to £40.2 million, or approximately €46.6 million. That figure includes £17.8 million in cash sitting on Acogroup’s balance sheet that transferred directly to the buyer at closing.
To secure the business, RWS acquired the outstanding debt instruments associated with the group. These included bonds issued by Acogroup subsidiary V.O. Paris and held by funds advised or managed by Barings. The acquisition converted those obligations into an intra-group liability within RWS until they are unwound. According to the company’s regulatory announcement, the transaction structure left RWS with no third-party debt inherited from the French business.
Closing the purchase required foreign investment clearance from French government officials overseeing the national economy and digital sovereignty. The transaction also required formal consultations with staff representatives across two Acogroup subsidiaries under French Works Council rules. Sellers granted exclusivity during those talks under a binding put option arrangement. Because both processes finished well ahead of the initial 31 March 2027 deadline, the companies closed the deal five months early, as RWS announced on 2 November 2026.
RWS funded the acquisition through existing banking facilities. The company had prepared its balance sheet by refinancing its revolving credit facility in October 2025, securing liquidity for targeted consolidation in the enterprise content sector. Under London Stock Exchange rules for the AIM market, where RWS trades, the acquisition qualified as a substantial transaction.
Expanding enterprise AI workflows across Europe
The deal unites two of Europe’s largest translation and localisation specialists at a moment when large language models are transforming commercial translation. Berkshire-based RWS turned over almost £700 million in its last financial year, driven by software platforms and managed language services for global corporations. Paris-based Acolad, founded in 1995, generated £182 million in revenue and £13 million in adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) in the year to 31 December 2025.
Enterprise translation has shifted away from purely human-led agencies toward hybrid production models. Providers combine automated neural translation platforms with human specialist review, known in the industry as post-editing. RWS has sought to position itself as a core supplier of enterprise AI content pipelines rather than a manual translation bureau.
The integration gives Acolad’s client base direct access to RWS’s software stack, including its Cultural Intelligence Layer, Language Weaver Pro, and the computer-assisted translation environment Trados. RWS intends to run customer translation memories and proprietary enterprise datasets through these platforms to increase throughput for large corporate accounts.
“This is a compelling acquisition that enhances our growth strategy as we deploy our AI content solutions,” said Benjamin Faes, chief executive officer of RWS. He said the group is already applying artificial intelligence at scale across its expert services to handle high-volume technical documentation.
Corporate demand for specialised AI services has driven similar transactions across software sectors, echoing how Digital Science acquires Jenni AI to weave automated language assistance directly into specialist professional workflows. As buyers demand higher margins from software, language technology vendors look to acquisitions to pool expensive engineering assets across broader customer rosters.
Regulated sectors and public institutions
Beyond language processing software, Acogroup gives RWS a strong defensive position in European public administration and regulated private markets. Regulated sectors generate approximately half of Acolad’s annual income. The firm maintains active supplier agreements with public institutions, European government bodies, and roughly half of the companies listed on France’s benchmark CAC 40 index.
Acolad’s medical device compliance division provides a direct commercial match for RWS’s life sciences unit, which has historically focused on global pharmaceutical contracts. Combining the two portfolios allows RWS to pitch bundled compliance services covering clinical trials, medical machinery documentation, and patent filings under strict European Union directives.
The business model also extends beyond digital document translation. Roughly 75% of Acolad’s revenue comes from localisation and related services, while the remaining 25% consists of spoken interpreting, live transcription, and specialized language data services. Acolad’s remote interpreting infrastructure will become part of RWS’s Transform operating segment.
Benjamin du Fraysseix, co-founder and former chief executive of Acolad, praised the combination when the deal was agreed. “Joining forces with RWS represents the natural next chapter of that journey,” he said. Acogroup held £404 million in gross assets at the end of 2025, reflecting an extensive physical and corporate footprint across Western Europe and North America.
Consolidation pressures in the language market
The acquisition highlights a broader shakeout across commercial localisation. General-purpose large language models have commoditised basic text translation, squeezing fees for routine commercial copy and forcing legacy agencies to either invest heavily in proprietary machine learning models or sell to scale operators.
Smaller agencies face escalating capital costs to maintain competitive server infrastructure, custom model fine-tuning, and data privacy safeguards required by corporate procurement officers. Many corporate buyers now expect machine translation to operate within audited security boundaries to prevent sensitive commercial text from training public models.
Larger operators that can afford dedicated cloud hosting and specialised language tooling are absorbing regional rivals to gain volume. Higher volumes allow firms to spread model development costs across millions of translated words. This push for operational scale aligns with corporate earnings across the sector, where AI earnings gains appear in third-quarter results among tech businesses that consolidate niche platforms.
RWS executives confirmed that the combined group will focus on retaining Acolad’s 1,200 employees while migrating redundant operational software over to the RWS internal technology stack. The primary management task ahead involves aligning Acolad’s distributed account teams with RWS’s product engineering groups in Maidenhead, ensuring enterprise accounts adopt the group’s proprietary tools without service disruption.
What happens next
With legal ownership transferred, RWS will begin migrating Acogroup’s client contracts onto its core technology architecture over the coming financial quarters. The AIM-listed group will report the acquired business under its Transform segment, detailing Acolad’s preliminary contribution in its next scheduled trading update to the London Stock Exchange.
Company management will monitor operational integration across the 22 operating territories, focusing on customer retention among CAC 40 clients and medical device manufacturers in France and Germany.
